跳至主要内容
临床试验/NCT04617041
NCT04617041已完成不适用

Assessment of DAFILON® Suture Material for Skin Closure: A Prospective, Multicentric, International, Single-arm, Observational Study in Daily Practice

Aesculap AG2 个研究点 分布在 2 个国家目标入组 115 人开始时间: 2021年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
115
试验地点
2
主要终点
Combination of Surgical Site Infection (SSI) and Wound Dehiscence

研究概览

简要总结

In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon®) will be evaluated for skin closure in adult and pediatric patients. The aim of the study is to collect clinical data on the performance of Dafilon® for skin closure. The results of this study will generate further clinical evidence for the use and the benefit of a non-absorbable surgical suture material produced from polyamide. Furthermore, the proactive collection of clinical data for Dafilon® suture will support the maintenance of the suture material on the market, so that in the future other patients can receive the suture material for skin closure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Combination of Surgical Site Infection (SSI) and Wound Dehiscence

时间窗: until suture removal 10±5 days postoperatively.

The hypotheses of the current study is that the combined endpoint which consists of the sum of the wound dehiscence and SSI rate will not be inferior to the rate of 13% published by Sajid M. S. et al., 2014 \[Systematic review of absorbable vs non-absorbable sutures used for the closure of surgical incisions. World J Gastrointest Surg 2014 27;6(12): 241-247\]

次要结局

  • Progress of Pain: Visual Analogue Scale (VAS)(until day of discharge (approximately 1-2 days postoperatively) and 10±5 days postoperatively)
  • Length of hospital stay(until day of discharge (approximately 1-2 days postoperatively))
  • Individual dehiscence rate at postoperative Examination(10±5 days postoperatively)
  • Progress of Wound healing(until day of discharge (approximately 1-2 days postoperatively), 10±5 days post operatively and at follow-up visit)
  • Progress of Satisfaction: Visual Analogue Scale (VAS)(until day of discharge (approximately 1-2 days postoperatively) and 10±5 days postoperatively)
  • Adverse events(until 10±5 days postoperatively)
  • Progress of Cosmetic result(at 10±5 days (suture removal) and at optional follow-up visit)
  • Rate of hypertrophic scar(10±5 days postoperatively (suture removal))
  • Rate of keloid scar(10±5 days postoperatively (suture removal))
  • Assessment of the handling of the suture material(intra-operatively)
  • Individual rate of surgical site infection (SSI) at discharge(until day of discharge (approximately 1-2 days postoperatively))
  • Individual rate of surgical site infection (SSI) at postoperative Examination(10±5 days postoperatively)
  • Individual dehiscence rate at discharge(until day of discharge (approximately 1-2 days postoperatively))

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验